100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting partim II Farmacologie $9.29   Add to cart

Summary

Samenvatting partim II Farmacologie

 49 views  3 purchases
  • Course
  • Institution

Samenvatting van partim II van Farmacologie, gebaseerd op de powerpoints en hoorcolleges. Gegeven in bachelor 2. Dit bevat NIET partim I.

Preview 4 out of 150  pages

  • May 11, 2022
  • 150
  • 2021/2022
  • Summary
avatar-seller
Farmacologie: partim II
Inhoud
1. Hypolipemiërende farmaca ................................................................................................................. 3
1.1 Inleiding ......................................................................................................................................... 3
1.2 Stoornissen in het lipidenmetabolisme ......................................................................................... 4
1.2.1 Atherosclerose & atherotrombose ........................................................................................ 5
1.3 Hypolipemiërende farmaca ........................................................................................................... 9
1.3.1 Statines (HMG-CoA reductase remmers) ............................................................................... 9
1.3.2 Fibraten (o.a. fenofibraat) .................................................................................................... 11
1.3.3 Harsen die galzuren binden .................................................................................................. 13
1.3.4 Remmers van de cholesteroltransporter in de darm ........................................................... 13
1.3.5 Visderivaten (omega 3 vetzure ethylesters)......................................................................... 14
1.3.6 PCSK9-inhibitoren ................................................................................................................. 14
1.4 Combinatie medicatie ................................................................................................................. 15
2. Farmacologie van het hart ................................................................................................................ 16
2.1 Inleiding ....................................................................................................................................... 16
2.2 Farmaca die de hartfunctie beïnvloeden .................................................................................... 16
2.2.1 Anti-aritmica ......................................................................................................................... 16
2.2.2 Hartglycosiden ...................................................................................................................... 22
2.2.3 Autonome neurotransmitters en verwante stoffen............................................................. 28
2.2.4 Anti-anginosa........................................................................................................................ 28
2.2.5 Calciumantagonisten ............................................................................................................ 34
3. Farmacologie van het vasculair systeem ........................................................................................... 37
3.1 Inleiding ....................................................................................................................................... 37
3.2 Vasoconstrictoren ....................................................................................................................... 38
3.3 Vasodilatoren .............................................................................................................................. 42
3.4 Geneesmiddelen.......................................................................................................................... 45
3.4.1 Geneesmiddelen bij hypertensie.......................................................................................... 45
3.4.2 Geneesmiddelen bij hartfalen met een gereduceerde ejectiefractie (HFrEF) ..................... 47
3.4.3 Geneesmiddelen bij angina pectoris .................................................................................... 49
3.4.4 Geneesmiddelen bij de ziekte van Raynaud......................................................................... 50
3.4.5 Geneesmiddelen bij pulmonaire hypertensie ...................................................................... 50
4. Farmacologie van de nier .................................................................................................................. 51
4.1 Inleiding ....................................................................................................................................... 51


1

, 4.2 Aangrijpingspunten voor medicatie ............................................................................................ 51
4.3 Diuretica ...................................................................................................................................... 54
5. Farmacologie van het respiratoir & GI systeem ................................................................................ 58
5.1 Farmacologie van het ademhalingsstelsel .................................................................................. 58
5.1.1 Regulatie van de luchtwegen ............................................................................................... 58
5.1.2 Astma.................................................................................................................................... 58
5.2 Farmacologie van het maagdarmstelsel...................................................................................... 65
5.2.1 Secretie van maagzuur, mucus & bicarbonaat ..................................................................... 65
5.2.2 Braken................................................................................................................................... 70
5.2.3 Constipatie............................................................................................................................ 74
5.2.4 Diarree: antidiarreïca............................................................................................................ 77
5.2.5 Spasmolytica ......................................................................................................................... 78
6. Farmacologie van het CZS ................................................................................................................. 79
6.1 Inleiding ....................................................................................................................................... 79
6.2 Neurotransmitters ....................................................................................................................... 80
6.2.1 Aminozuren .......................................................................................................................... 80
6.2.2 Noradrenaline in het CZS ...................................................................................................... 84
6.2.3 Dopamine in het CZS ............................................................................................................ 84
6.2.4 5-HT (serotonine) in het CZS ................................................................................................ 86
6.2.5 Acetylcholine in het CZS ....................................................................................................... 87
6.2.6 Histamine.............................................................................................................................. 88
6.2.7 Purines .................................................................................................................................. 88
6.2.8 Melatonine ........................................................................................................................... 89
6.2.9 NO ......................................................................................................................................... 89
6.3 Neurodegeneratieve aandoeningen ........................................................................................... 89
6.3.1 Ziekte van Alzheimer ............................................................................................................ 91
6.3.2 Ziekte van Parkinson............................................................................................................. 93
6.4 Antipsychotica ( = neuroleptica).................................................................................................. 98
6.4.1 Werkingsmechanisme ........................................................................................................ 100
6.4.2 Classificatie ......................................................................................................................... 102
6.5 Antidepressiva ........................................................................................................................... 106
6.5.1 Inleiding .............................................................................................................................. 106
6.5.2 Werkingsmechanismen ...................................................................................................... 107
6.5.3 Stemmingsstabilisatoren .................................................................................................... 114
6.6 Anxiolytica & hypnosedativa ..................................................................................................... 116
6.6.1 Benzodiazepines ................................................................................................................. 117

2

, 6.6.2 Barbituraten ....................................................................................................................... 119
6.7 Anti-eleptica .............................................................................................................................. 119
6.7.1 Epilepsie.............................................................................................................................. 119
6.7.2 Anti-eleptica ....................................................................................................................... 120
6.7.3 Samenvattend .................................................................................................................... 123
7 Opioïden (analgetica) ....................................................................................................................... 124
7.1 Inleiding ..................................................................................................................................... 124
7.2 Nociceptieve pijn ....................................................................................................................... 125
7.3 Analgetica: opioïden .................................................................................................................. 128
7.3.1 Inleiding .............................................................................................................................. 128
7.3.2 Werkingsmechanisme van de opioïden ............................................................................. 129
7.3.3 Indeling opioïde analgetica ................................................................................................ 140
7.3.4 Opioïd antagonisten ........................................................................................................... 143
7.3.5 Interacties met opioïden .................................................................................................... 144
7.4 Samenvattend ........................................................................................................................... 145
8. Lokale anesthetica ........................................................................................................................... 146
8.1 Inleiding ..................................................................................................................................... 146
8.2 Werkingsmechanisme ............................................................................................................... 147
8.3 Gebruik ...................................................................................................................................... 148
8.4 Verschillende types en toedieningswijze .................................................................................. 149



1. Hypolipemiërende farmaca
→ zeer veel gebruikte GM, vnl.: statines (goed kennen!).

1.1 Inleiding
Lipoproteïnetransport in het bloed
Componenten:

• Chylomicronen
o Functie: gaan TG en cholesterol vanuit de GI-tractus naar
de weefsels transporteren.
o Lipoproteïne lipase → zorgt voor de omzetting van TG in
glycerol en vrije vetzuren (bouwstenen).
▪ Vrije vetzuren worden verder opgenomen
(afbeelding: thv de vaatwand)
o Chylomicron remnants = restanten van de chylomicronen wanneer ze hun TG hebben
vrijgegeven.
▪ Worden naar de lever getransporteerd (in hepatocyt), verschillende opties:
• Opgestapeld, gesecreteerd in de gal of geoxideerd tot galzuren
• Op zich geoxideerd


3

, • Omgezet naar VLDL partikels
• VLDL (very low density lipoproteins)
o Bevat:
▪ Heel wat cholesterol
▪ Ook heel wat nieuw gesynthetiseerde TG
o TG in de VLDL → worden ook via lipoproteïne lipase omgezet tot glycerol en vrije
vetzuren → vrije vetzuren opgenomen.
▪ LET OP: daarnaast ook LDL gevormd.
• LDL (low density lipoproteins)
o = ‘slechte cholesterol’
o Bevat
▪ Geen TG
▪ Wel cholesterol esthers (hoog gehalte aan cholesterol)
o Cholesterol esters → wordt opgenomen door weefsels & de lever (via endocytose
m.b.v. specifieke LDL-receptoren)
• HDL (high density lipoproteins)
o = ‘goede cholesterol’
o Functie: nemen cholesterol (celturnover) vanuit de weefsels en de arteriën(!) op →
verder omgezet naar: VLDL & LDL.




Opm.: daarnaast ook IDL (intermediate density lipoproteins).

1.2 Stoornissen in het lipidenmetabolisme
= dyslipidemie


4

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller stabiloboss. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $9.29. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

80364 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$9.29  3x  sold
  • (0)
  Add to cart